brand logo

Am Fam Physician. 2006;73(6):974

The article “Warfarin Therapy: Evolving Strategies in Anticoagulation” (February 1, 1999, page 635) incorrectly stated that the carboxylation of certain glutamic acid residues, which make clotting factors II, VII, IX, and X as well as anticoagulant proteins C and S biologically active, requires an oxidized vitamin K as a cofactor. The article should read, “This carboxylation process requires a reduced vitamin K as a cofactor.” The online version of this article has been corrected.

Continue Reading


More in AFP

Copyright © 2006 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See https://www.aafp.org/about/this-site/permissions.html for copyright questions and/or permission requests.